EGFR and pancreatic neuroendocrine tumor: For pancreatic neuroendocrine tumors (PNETs), Marinovic et al. emphasized that the combination of EGF, EGFR, and HER2 plays a significant role in carcinogenesis and impacts susceptibility to various treatment strategies.